目的:探讨利胆通舒汤灌肠治疗对腹腔镜胆囊切除术(LC)后患者的不良反应的有效性。方法:回顾性分析2022-05至2024-05黑龙江中医药大学附属第一医院外二科行LC的68例胆囊结石患者,对照组和观察组各34例。术后给予常规治疗,观察组在对照组...目的:探讨利胆通舒汤灌肠治疗对腹腔镜胆囊切除术(LC)后患者的不良反应的有效性。方法:回顾性分析2022-05至2024-05黑龙江中医药大学附属第一医院外二科行LC的68例胆囊结石患者,对照组和观察组各34例。术后给予常规治疗,观察组在对照组基础治疗上增加利胆通舒汤灌肠,比较2组患者的术后第1 d、第5 d腹痛、腹胀情况以及白细胞计数、淋巴细胞百分比、中性粒细胞百分比、ALT、AST情况。结果:观察组在术后第5 d腹痛视觉模拟评分(VAS)小于对照组(P 0.05)。结论:与对照组相比,LC后给予利胆通舒汤灌肠能减轻患者腹痛、腹胀不适症状,降低炎症反应,促进患者术后恢复。Objective: This study aims to explore the effectiveness of Lidan Tongshu Decoction enema in mitigating postoperative adverse reactions in patients undergoing laparoscopic cholecystectomy (LC). Methods: A retrospective analysis was conducted on 68 patients with gallstones who underwent LC between May 2022 and May 2024 at the Second Department of Surgery, First Affiliated Hospital of Heilongjiang University of Chinese Medicine. The patients were divided into a control group and an observation group, each comprising 34 cases. Postoperatively, both groups received standard treatment, with the observation group receiving an additional Lidan Tongshu Decoction enema. The two groups were compared in terms of postoperative abdominal pain and bloating on day 1 and day 5, as well as white blood cell count, lymphocyte percentage, neutrophil percentage, ALT, and AST levels. Results: On postoperative day 5, the Visual Analog Scale (VAS) score for abdominal pain was significantly lower in the observation group compared to the control group (P 0.05). Conclusion: Compared to the control group, the administration of Lidan Tongshu Decoction enema after LC can alleviate symptoms of abdominal pain and bloating, reduce inflammatory responses, and promote postoperative recovery.展开更多
文摘目的:探讨利胆通舒汤灌肠治疗对腹腔镜胆囊切除术(LC)后患者的不良反应的有效性。方法:回顾性分析2022-05至2024-05黑龙江中医药大学附属第一医院外二科行LC的68例胆囊结石患者,对照组和观察组各34例。术后给予常规治疗,观察组在对照组基础治疗上增加利胆通舒汤灌肠,比较2组患者的术后第1 d、第5 d腹痛、腹胀情况以及白细胞计数、淋巴细胞百分比、中性粒细胞百分比、ALT、AST情况。结果:观察组在术后第5 d腹痛视觉模拟评分(VAS)小于对照组(P 0.05)。结论:与对照组相比,LC后给予利胆通舒汤灌肠能减轻患者腹痛、腹胀不适症状,降低炎症反应,促进患者术后恢复。Objective: This study aims to explore the effectiveness of Lidan Tongshu Decoction enema in mitigating postoperative adverse reactions in patients undergoing laparoscopic cholecystectomy (LC). Methods: A retrospective analysis was conducted on 68 patients with gallstones who underwent LC between May 2022 and May 2024 at the Second Department of Surgery, First Affiliated Hospital of Heilongjiang University of Chinese Medicine. The patients were divided into a control group and an observation group, each comprising 34 cases. Postoperatively, both groups received standard treatment, with the observation group receiving an additional Lidan Tongshu Decoction enema. The two groups were compared in terms of postoperative abdominal pain and bloating on day 1 and day 5, as well as white blood cell count, lymphocyte percentage, neutrophil percentage, ALT, and AST levels. Results: On postoperative day 5, the Visual Analog Scale (VAS) score for abdominal pain was significantly lower in the observation group compared to the control group (P 0.05). Conclusion: Compared to the control group, the administration of Lidan Tongshu Decoction enema after LC can alleviate symptoms of abdominal pain and bloating, reduce inflammatory responses, and promote postoperative recovery.
